Status:
NOT_YET_RECRUITING
Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study
Lead Sponsor:
Scentech Medical Technologies Ltd
Conditions:
Colorectal Cancer
Pancreatic Cancer
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Detection of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study
Detailed Description
A diagnostic prospective study with no anticipated risks or constraints. Main Objective: To quantify differences in exhaled breath VOCs of patients with colorectal or pancreatic cancers compared with ...
Eligibility Criteria
Inclusion
- Age 18 to 85 years at the time of consent.
- Scheduled for colonoscopy or Endoscopic Retrograde Cholangio Pancreatography.
- Fasted \>6 hours, consuming water only.
- Able to provide informed written consent.
Exclusion
- Lacks capacity or is unable to provide informed written consent.
- Pregnant or lactating woman.
- Histologically confirmed cancer in any organ.
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05400408
Start Date
May 1 2024
End Date
March 31 2025
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shamir Medical Center
Be’er Ya‘aqov, Israel